LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 03 June 2021I |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
|
||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
5,289,877 |
2.10% |
104,822 |
0.04% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
65,455 |
0.03% |
4,827,471 |
1.92% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
5,355,332 |
2.13% |
4,932,293 |
1.96% |
||
|
|
|
|
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities |
Price per unit |
| Purchase | 139 |
10.5706 GBP |
| Purchase | 1,563 |
10.5813 GBP |
| Purchase | 2,050 |
10.5853 GBP |
| Purchase | 4,255 |
10.5700 GBP |
| Purchase | 4,616 |
10.5727 GBP |
| Purchase | 6,374 |
10.5719 GBP |
| Purchase | 6,491 |
10.5782 GBP |
| Purchase | 11,415 |
10.5691 GBP |
| Purchase | 29,127 |
10.5711 GBP |
| Purchase | 104,734 |
10.6000 GBP |
| Sale | 39 |
10.5761 GBP |
| Sale | 100 |
10.5700 GBP |
| Sale | 273 |
10.5800 GBP |
| Sale | 279 |
10.5750 GBP |
| Sale | 291 |
10.5900 GBP |
| Sale | 381 |
10.5850 GBP |
| Sale | 851 |
10.5766 GBP |
| Sale | 1,099 |
10.5744 GBP |
| Sale | 1,246 |
10.5757 GBP |
| Sale | 1,485 |
10.5811 GBP |
| Sale | 1,822 |
10.5763 GBP |
| Sale | 2,201 |
10.5704 GBP |
| Sale | 10,542 |
10.5831 GBP |
| Sale | 14,734 |
10.6005 GBP |
| Sale | 41,032 |
10.5662 GBP |
| Sale | 120,784 |
10.5948 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities |
Price per |
|
unit | ||
| CFD | Long | 621 |
10.5785 GBP |
| SWAP | Long | 5,696 |
10.5927 GBP |
| SWAP | Long | 8,535 |
10.5733 GBP |
| SWAP | Long | 8,952 |
10.5743 GBP |
| SWAP | Long | 11,526 |
10.5796 GBP |
| SWAP | Long | 16,633 |
10.5794 GBP |
| SWAP | Short | 51 |
10.5600 GBP |
| CFD | Short | 2,050 |
10.5853 GBP |
| SWAP | Short | 2,101 |
10.5800 GBP |
| SWAP | Short | 19,094 |
10.5823 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 4 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |